Daiichi Sankyo appoints Markus Kosch to lead European business

Daiichi Sankyo has announced the appointment of Markus Kosch, MD, as Head of Europe Business, effective April 1, 2027. In this capacity, Kosch will lead the company’s European operations within a newly established, globally integrated Commercialization Unit and serve as General Manager of Daiichi Sankyo Europe GmbH.

The move is part of the company’s Five-Year Business Plan and aims to integrate the Oncology and Specialty businesses in Europe under a single leadership model. Kosch, who has led the company’s Oncology Business Division in Europe and Canada for the past five years, will oversee the expansion of the company’s oncology portfolio.

Additionally, Ken Keller has been appointed to the newly created role of Chief Commercialization Officer, also effective April 1, 2027.